Earnings roundup: Angiotech, Plum Creek Timber

NEW YORK (AP)--Medical product maker Angiotech Pharmaceuticals Inc. reported a wider second-quarter loss Monday as its research and development costs grew.

SEATTLE (AP)--Plum Creek Timber Co., a real estate investment trust, said Monday its second-quarter earnings dropped by nearly half due to a challenging lumber market and an impairment charge, but still beat Wall Street's expectations.

ACTON, Mass. (AP)--Psychemedics Corp., which performs hair testing services to detect drug use, said Monday its second-quarter profit fell 22 percent as a weak job market cut into the company's revenue.